AGCE gene transcriptions: Difference between revisions
mNo edit summary |
|||
Line 2: | Line 2: | ||
[[Image:Bjs48 02 Ainu.jpg|thumb|right|250px|This is a restored image of a group of Ainu men between 1863 and early 1870s. Credit: Felice Beato.]] | [[Image:Bjs48 02 Ainu.jpg|thumb|right|250px|This is a restored image of a group of Ainu men between 1863 and early 1870s. Credit: Felice Beato.]] | ||
'''Angiotensinogen core promoter element''' 1 (AGCE1) is an example of a core promoter element that may occur in a DNA sequence for only one gene (the human angiotensinogen gene angiotensin). | '''Angiotensinogen core promoter element''' 1 (AGCE1) is an example of a core promoter element that may occur in a DNA sequence for only one gene (the human angiotensinogen gene angiotensin). | ||
"[T]he core promoter element 1 (AGCE1) of the human angiotensinogen gene (''AGT'') ... acts as a critical regulator of ''AGT'' transcription".<ref name=Sato/> | |||
{{clear}} | {{clear}} | ||
==Human genes== | ==Human genes== | ||
{{main|Human genes}} | {{main|Human genes}} | ||
Gene ID: 183 is angiotensinogen (serpin peptidase inhibitor, clade A, member 8) [ Homo sapiens ] has the official symbol AGT.<ref name=HGNC183>{{ cite web | |||
|author=HGNC | |author=HGNC | ||
|title=AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8) [ Homo sapiens ] | |title=AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8) [ Homo sapiens ] | ||
Line 25: | Line 17: | ||
|accessdate=2013-02-10 }}</ref> | |accessdate=2013-02-10 }}</ref> | ||
== | ==Consensus sequences== | ||
{{main| | {{main|Consensus sequence gene transcriptions}} | ||
The consensus sequence is 3'-A/C-T-C/T-5'.<ref name=Sato/> By convention, this is 5'-MTY-3' on the mRNA, with T replaced by uracil (U). | |||
The core nucleotides for AGCE1 include 3'-A/C-T-C/T-G-T-G-5', "located between the TATA box and [[Transcription start site|transcription initiation site]] (positions −25 to −1) is an authentic regulator of human AG transcription."<ref name=Yanai>{{ cite journal | |||
|author=Kazuyuki Yanai, Tomoko Saito, Keiko Hirota, Hideyuki Kobayashi, Kazuo Murakami and Akiyoshi Fukamizu | |author=Kazuyuki Yanai, Tomoko Saito, Keiko Hirota, Hideyuki Kobayashi, Kazuo Murakami and Akiyoshi Fukamizu | ||
|title=Molecular Variation of the Human Angiotensinogen Core Promoter Element Located between the TATA Box and Transcription Initiation Site Affects Its Transcriptional Activity | |title=Molecular Variation of the Human Angiotensinogen Core Promoter Element Located between the TATA Box and Transcription Initiation Site Affects Its Transcriptional Activity | ||
Line 41: | Line 35: | ||
|pmid= 9374551 | |pmid= 9374551 | ||
|accessdate=2012-02-20 }}</ref> | |accessdate=2012-02-20 }}</ref> | ||
==A1BG gene transcriptions== | ==A1BG gene transcriptions== | ||
Line 72: | Line 58: | ||
==Core promoters== | ==Core promoters== | ||
{{main|Core promoter gene transcriptions}} | {{main|Core promoter gene transcriptions}} | ||
AGCE1 can occur upstream from -25 to -1 base pairs (bp)s of the transcription start site.<ref name=Sato>{{ cite journal | AGCE1 can occur upstream from -25 to -1 base pairs (bp)s of the transcription start site.<ref name=Sato>{{ cite journal | ||
|author=Noriyuki Sato; Tomohiro Katsuya; Hiromi Rakugi; Seiju Takami; Yukiko Nakata; Tetsuro Miki; Jitsuo Higaki; Toshio Ogihara | |author=Noriyuki Sato; Tomohiro Katsuya; Hiromi Rakugi; Seiju Takami; Yukiko Nakata; Tetsuro Miki; Jitsuo Higaki; Toshio Ogihara | ||
Line 104: | Line 88: | ||
{{div col|colwidth=20em}} | {{div col|colwidth=20em}} | ||
* [[A1BG gene transcriptions]] | * [[A1BG gene transcriptions]] | ||
* [[Angiotensinogen core promoter element gene transcriptions]] | |||
* [[Biochemistry]] | * [[Biochemistry]] | ||
* [[Eukaryotic transcription]] | * [[Eukaryotic transcription]] | ||
Line 112: | Line 97: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
==External links== | ==External links== | ||
* [http://www.genome.jp/ GenomeNet KEGG database] | * [http://www.genome.jp/ GenomeNet KEGG database] | ||
* [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene Home - Gene - NCBI] | * [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene Home - Gene - NCBI] | ||
* [http://www.ncbi.nlm.nih.gov/sites/gquery NCBI All Databases Search] | * [http://www.ncbi.nlm.nih.gov/sites/gquery NCBI All Databases Search] | ||
* [http://www.ncbi.nlm.nih.gov/pccompound PubChem Public Chemical Database] | * [http://www.ncbi.nlm.nih.gov/pccompound PubChem Public Chemical Database] | ||
<!-- footer templates --> | <!-- footer templates --> |
Revision as of 17:15, 7 October 2020
Associate Editor(s)-in-Chief: Henry A. Hoff
Angiotensinogen core promoter element 1 (AGCE1) is an example of a core promoter element that may occur in a DNA sequence for only one gene (the human angiotensinogen gene angiotensin).
"[T]he core promoter element 1 (AGCE1) of the human angiotensinogen gene (AGT) ... acts as a critical regulator of AGT transcription".[1]
Human genes
Gene ID: 183 is angiotensinogen (serpin peptidase inhibitor, clade A, member 8) [ Homo sapiens ] has the official symbol AGT.[2]
Consensus sequences
The consensus sequence is 3'-A/C-T-C/T-5'.[1] By convention, this is 5'-MTY-3' on the mRNA, with T replaced by uracil (U).
The core nucleotides for AGCE1 include 3'-A/C-T-C/T-G-T-G-5', "located between the TATA box and transcription initiation site (positions −25 to −1) is an authentic regulator of human AG transcription."[3]
A1BG gene transcriptions
An AGCE1 occurs at 3'-ATC-5', in the nucleotides before the transcription start site for the transcription of A1BG, which ends 5 bp upstream from the TSS and is the only AGCE1 within -25 and -1 bp of the TSS. Usually, the AGCE1 spans -20 to -18 bp, when a TATA box is present.[1]
However, for the transcription of A1BG, there is no TATA box and the core nucleotides 3'-GTG-5' do not occur on either side of 3'-ATC-5'.
Hypotheses
- AGCE1 does not participate in the transcription of A1BG.
Samplings
- AGCE, negative strand, negative direction, looking for 3'-A/C-T-C/T-G-T-G-5': 4 between 340 and 3914 nts and complements.
- AGCE, negative strand, positive direction, looking for 3'-A/C-T-C/T-G-T-G-5': 2, 3'-ATTGTG-5' at 2679, 3'-CTCGTG-5' at 4376 and complements.
- AGCE, positive strand, positive direction, looking for 3'-A/C-T-C/T-G-T-G-5': 6 between 855 and 3739 and complements.
- AGCEci, negative strand, negative direction, looking for 3'-C-A-C-A/G-A-G/T-5': 2, 3'-CACGAT-5' at 336, 3'-CACGAG-5' at 4403 and complements.
- AGCEci, negative strand, positive direction, looking for 3'-C-A-C-A/G-A-G/T-5': 1, 3'-CACGAG-5' at 243.
- AGCEci, positive strand, negative direction, looking for 3'-C-A-C-A/G-A-G/T-5': 10 between 435 and 4472 and complements.
- AGCEci, positive strand, positive direction, looking for 3'-C-A-C-A/G-A-G/T-5': 3 between 107 and 3152 and complements.
Core promoters
AGCE1 can occur upstream from -25 to -1 base pairs (bp)s of the transcription start site.[1]
Proximal promoters
Distal promoters
Acknowledgements
The content on this page was first contributed by: Henry A. Hoff.
Initial content for this page in some instances came from Wikiversity.
See also
References
- ↑ 1.0 1.1 1.2 1.3 Noriyuki Sato; Tomohiro Katsuya; Hiromi Rakugi; Seiju Takami; Yukiko Nakata; Tetsuro Miki; Jitsuo Higaki; Toshio Ogihara (September 1997). "Association of Variants in Critical Core Promoter Element of Angiotensinogen Gene With Increased Risk of Essential Hypertension in Japanese". Hypertension. 30 (3 Pt 1): 321–5. doi:10.1161/01.HYP.30.3.321. PMID 9314411. Retrieved 2012-02-20.
- ↑ HGNC (February 7, 2013). "AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8) [ Homo sapiens ]". 8600 Rockville Pike, Bethesda MD, 20894 USA: National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved 2013-02-10.
- ↑ Kazuyuki Yanai, Tomoko Saito, Keiko Hirota, Hideyuki Kobayashi, Kazuo Murakami and Akiyoshi Fukamizu (28 November 1997). "Molecular Variation of the Human Angiotensinogen Core Promoter Element Located between the TATA Box and Transcription Initiation Site Affects Its Transcriptional Activity". The Journal of Biological Chemistry. 272 (48): 30558–62. PMID 9374551. Retrieved 2012-02-20.